368 related articles for article (PubMed ID: 18191350)
21. An experimental study on MR imaging of atherosclerotic plaque with SPIO marked endothelial cells in a rabbit model.
Zhou Q; Yang KR; Gao P; Chen WL; Yang DY; Liang MJ; Zhu L
J Magn Reson Imaging; 2011 Dec; 34(6):1325-32. PubMed ID: 21953575
[TBL] [Abstract][Full Text] [Related]
22. Superparamagnetic iron oxide magnetic nanomaterial-labeled bone marrow mesenchymal stem cells for rat liver repair after hepatectomy.
Zhao S; Wang Y; Gao C; Zhang J; Bao H; Wang Z; Gong P
J Surg Res; 2014 Oct; 191(2):290-301. PubMed ID: 24780414
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of drug loaded glycyrrhetinic acid modified alginate nanoparticles on mice bearing orthotopic liver tumor.
Zhang C; Wu Y; Liu T; Zhao Y; Wang X; Wang W; Yuan Z
J Control Release; 2011 Nov; 152 Suppl 1():e111-3. PubMed ID: 22195787
[No Abstract] [Full Text] [Related]
24. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
Stoll G; Bendszus M
Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
[TBL] [Abstract][Full Text] [Related]
25. Design of iron oxide/silica/alginate hybrid magnetic carriers (HYMAC).
Boissière M; Allouche J; Brayner R; Chanéac C; Livage J; Coradin T
J Nanosci Nanotechnol; 2007 Dec; 7(12):4649-54. PubMed ID: 18283857
[TBL] [Abstract][Full Text] [Related]
26. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Prashant C; Dipak M; Yang CT; Chuang KH; Jun D; Feng SS
Biomaterials; 2010 Jul; 31(21):5588-97. PubMed ID: 20434210
[TBL] [Abstract][Full Text] [Related]
27. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
Smirnov P
Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287
[TBL] [Abstract][Full Text] [Related]
28. Macrophage physiological function after superparamagnetic iron oxide labeling.
Hsiao JK; Chu HH; Wang YH; Lai CW; Chou PT; Hsieh ST; Wang JL; Liu HM
NMR Biomed; 2008 Oct; 21(8):820-9. PubMed ID: 18470957
[TBL] [Abstract][Full Text] [Related]
29. Alginate-coated magnetic nanoparticles for noninvasive MRI of extracellular calcium.
Bar-Shir A; Avram L; Yariv-Shoushan S; Anaby D; Cohen S; Segev-Amzaleg N; Frenkel D; Sadan O; Offen D; Cohen Y
NMR Biomed; 2014 Jul; 27(7):774-83. PubMed ID: 24764262
[TBL] [Abstract][Full Text] [Related]
30. Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents.
Meng XX; Wan JQ; Jing M; Zhao SG; Cai W; Liu EZ
Acta Pharmacol Sin; 2007 Dec; 28(12):2019-26. PubMed ID: 18031618
[TBL] [Abstract][Full Text] [Related]
31. [Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles in detecting lymph node metastasis of tumors: an experimental study].
Wu YK; Xu YK; Zhang JN; Wu FL; Liu XY; Huang QL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):62-4. PubMed ID: 12527520
[TBL] [Abstract][Full Text] [Related]
32. Enhanced aggregation of alginate-coated iron oxide (hematite) nanoparticles in the presence of calcium, strontium, and barium cations.
Chen KL; Mylon SE; Elimelech M
Langmuir; 2007 May; 23(11):5920-8. PubMed ID: 17469860
[TBL] [Abstract][Full Text] [Related]
33. Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration.
Bacon BR; Stark DD; Park CH; Saini S; Groman EV; Hahn PF; Compton CC; Ferrucci JT
J Lab Clin Med; 1987 Aug; 110(2):164-71. PubMed ID: 3598345
[TBL] [Abstract][Full Text] [Related]
34. Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging.
Bomatí-Miguel O; Morales MP; Tartaj P; Ruiz-Cabello J; Bonville P; Santos M; Zhao X; Veintemillas-Verdaguer S
Biomaterials; 2005 Oct; 26(28):5695-703. PubMed ID: 15878375
[TBL] [Abstract][Full Text] [Related]
35. Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid).
Thünemann AF; Schütt D; Kaufner L; Pison U; Möhwald H
Langmuir; 2006 Feb; 22(5):2351-7. PubMed ID: 16489828
[TBL] [Abstract][Full Text] [Related]
36. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2006 May; 27(5):409-16. PubMed ID: 16624533
[TBL] [Abstract][Full Text] [Related]
38. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Khdair A; Gerard B; Bachmeier C; Miller DW; Shekhar MP; Panyam J
Mol Pharm; 2007; 4(5):730-8. PubMed ID: 17705442
[TBL] [Abstract][Full Text] [Related]
39. [Preparation and characterization of superparamagnetic iron oxide nanoparticles].
Liu ST; Yan Y; Chen ZL; Zhang YZ; Jin X
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):331-4. PubMed ID: 16546740
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]